Q4 2024 Earnings Call Transcript February 6, 2025 Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is ...

Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Q4 2024 Management View CEO Chris Boerner highlighted a robust performance in Q4 2024, driven by double-digit growth in the company’s growth portfolio, including key products like Breyanzi, Camzyos, ...

Target 7 breaks down a series of case dismissals due to competency and the extensive costs it can have on law enforcement.

The stories were stunning, allegations about fertility treatment physicians who secretly used their own sperm to impregnate ...

When it comes to the potential of H5N1 avian flu, otherwise known as bird flu, picking up mutations that may lead to human-to ...

Resilience factors were associated with less severe positive and negative schizophrenia symptoms, suggesting resilience may play a protective role.